Product Information
HYDROCHLOROTHIAZIDE 12.5 MG TB is a generic product labeled by Actavis Pharma, Inc., priced at $0.0404 per EA under NDC 00228282011. Its NADAC has been published 657 times since Nov 28, 2013.
The High Outlier badge above means this manufacturer's average price in the Hydrochlorothiazide market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
12.5 mg/1
Manufacturer
Actavis Pharma, Inc.NDC
00228282011
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
HYDROCHLOROTHIAZIDEApproval Type
Generic (ANDA)
FDA Application
ANDA040707On Market Since
3/12/2007
Pharmacological Classes
Price Statistics
The NADAC for HYDROCHLOROTHIAZIDE 12.5 MG TB has been published 657 times since Nov 28, 2013, and over the history we have for it it has declined 78.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0404 per EA |
|---|---|
| All-time high | $0.1912 (Dec 11, 2013) |
| All-time low | $0.0345 (Nov 20, 2024) |
| 52-week high | $0.0458 |
| 52-week low | $0.0403 |
| Median price | $0.0651 |
| Average price | $0.0768 |
| Largest weekly change | +51.5% (Jan 17, 2018) |
| Weeks tracked | 657 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 10 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 10 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 30% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of HYDROCHLOROTHIAZIDE 12.5 MG TB?
The current National Average Drug Acquisition Cost (NADAC) for HYDROCHLOROTHIAZIDE 12.5 MG TB, manufactured by Actavis Pharma, Inc., is $0.0404 per EA (NDC 00228282011), effective Jun 24, 2026.
How has the price of HYDROCHLOROTHIAZIDE 12.5 MG TB changed over time?
Over the history we have for it, the NADAC for HYDROCHLOROTHIAZIDE 12.5 MG TB has declined 78.9%. It has been tracked across 657 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for HYDROCHLOROTHIAZIDE 12.5 MG TB?
Since Nov 28, 2013, the NADAC for HYDROCHLOROTHIAZIDE 12.5 MG TB has ranged from a low of $0.0345 (Nov 20, 2024) to a high of $0.1912 (Dec 11, 2013), with a median of $0.0651 per EA.
Are there cheaper alternatives to HYDROCHLOROTHIAZIDE 12.5 MG TB?
Yes. 10 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, HYDROCHLOROTHIAZIDE 12.5 MG CP, is $0.0284 per EA — about 30% below HYDROCHLOROTHIAZIDE 12.5 MG TB.
Who manufactures HYDROCHLOROTHIAZIDE 12.5 MG TB?
HYDROCHLOROTHIAZIDE 12.5 MG TB (NDC 00228282011) is labeled by Actavis Pharma, Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification